Last $2.56 USD
Change Today +0.08 / 3.23%
Volume 298.3K
SNSS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 1:48 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Homer L. Pearce Ph.D.

Director and Chairman of Nominating & Corporate Governance Committee, Sunesis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 75 board members in 10 different organizations across 10 different industries.

See Board Relationships
61--

Background*

Dr. Homer L. Pearce, Ph.D., serves as Executive Vice President of Drug Development at Human Genome Sciences and is responsible for clinical research, development and regulatory activities. Dr. Pearce is an Industry Expert at Pearl Street Venture Funds. Dr. Pearce served as Vice President of Oncology at Eli Lilly & Co. Dr. Pearce held various leadership positions in cancer drug discovery and development for more than 27 years at Eli Lilly & Company. He has been committed ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

Director
Director and Member of Scientific Advisory Board
Director
2006-Present
Director and Chairman of Nominating & Corporate Governance Committee

Education*

PhD 1979
Harvard University
BS 1974
Texas A&M University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNSS:US $2.56 USD +0.08

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.